SAUD O ABAALKHAIL

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology MINNEAPOLIS, MN NPI 1982180733

General Payments — all program years on this page

$2,672.72

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $804.77 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $804.7713

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $346.384
Alexion Pharmaceuticals, Inc. $124.021
UCB, Inc. $120.861
Aurinia Pharma U.S., Inc. $84.203
Lilly USA, LLC $70.111
Acerta Pharma LLC $40.982
GlaxoSmithKline, LLC. $18.221

By program year

Program yearAmountRecords
2018 $13.911
2019 $334.9319
2020 $148.868
2021 $379.5314
2022 $990.7225
2023 $804.7713

Records — PY2023 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1003100767 GlaxoSmithKline, LLC. $18.22 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011598039 AstraZeneca Pharmaceuticals LP $20.56 01/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014461814 AstraZeneca Pharmaceuticals LP $20.42 01/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1016979055 Alexion Pharmaceuticals, Inc. $124.02 04/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1021874927 UCB, Inc. $120.86 05/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032298201 Lilly USA, LLC $70.11 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057724865 Aurinia Pharma U.S., Inc. $26.68 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057724869 Aurinia Pharma U.S., Inc. $28.92 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057724871 Aurinia Pharma U.S., Inc. $28.60 04/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996074651 AbbVie Inc. $125.00 05/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996074653 AbbVie Inc. $123.71 06/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996074655 AbbVie Inc. $33.47 06/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996074657 AbbVie Inc. $64.20 11/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.